chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Myalgia, Nausea
Clinical narrative: COVID-19 virus; Coughing; sore throat; nausea; headache; chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID-19 virus), COUGH (Coughing), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea) and HEADACHE (headache) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 virus), COUGH (Coughing), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea), HEADACHE (headache), CHILLS (chills) and MYALGIA (Body aches). The patient was treated with GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (COVID-19 virus), COUGH (Coughing), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea), HEADACHE (headache), CHILLS (chills) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: COVID-19 virus; Coughing; sore throat; nausea; headache; chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID-19 virus), COUGH (Coughing), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea) and HEADACHE (headache) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 virus), COUGH (Coughing), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea), HEADACHE (headache), CHILLS (chills) and MYALGIA (Body aches). The patient was treated with GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (COVID-19 virus), COUGH (Coughing), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea), HEADACHE (headache), CHILLS (chills) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Influenza like illness, Malaise, Myalgia
Clinical narrative: Pronounced redness around the injection site, there is also a white line around redness; chills; Body aches; She was not well; Flu like symptoms; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), MALAISE (She was not well), INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE ERYTHEMA (Pronounced redness around the injection site, there is also a white line around redness) and CHILLS (chills) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DIZZINESS (Dizziness). On 12-Feb-2021, the patient experienced MALAISE (She was not well), INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (chills) and MYALGIA (Body aches). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Pronounced redness around the injection site, there is also a white line around redness). On 11-Feb-2021, DIZZINESS (Dizziness) had resolved. On 15-Feb-2021, MALAISE (She was not well), INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (chills) and MYALGIA (Body aches) had resolved. On 16-Feb-2021, VACCINATION SITE ERYTHEMA (Pronounced redness around the injection site, there is also a white line around redness) had resolved. Not Provided          Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Pronounced redness around the injection site, there is also a white line around redness; chills; Body aches; She was not well; Flu like symptoms; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), MALAISE (She was not well), INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE ERYTHEMA (Pronounced redness around the injection site, there is also a white line around redness) and CHILLS (chills) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DIZZINESS (Dizziness). On 12-Feb-2021, the patient experienced MALAISE (She was not well), INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (chills) and MYALGIA (Body aches). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Pronounced redness around the injection site, there is also a white line around redness). On 11-Feb-2021, DIZZINESS (Dizziness) had resolved. On 15-Feb-2021, MALAISE (She was not well), INFLUENZA LIKE ILLNESS (Flu like symptoms), CHILLS (chills) and MYALGIA (Body aches) had resolved. On 16-Feb-2021, VACCINATION SITE ERYTHEMA (Pronounced redness around the injection site, there is also a white line around redness) had resolved. Not Provided          Concomitant medications were not provided. Treatment information was not reported.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Lethargy, Pain in extremity, Rash
Clinical narrative: horrible pain in patients' legs; rash on face/rash halfway down patients' chest; lethargic; Patient feels dizzy; patient feels like he is not all there; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (horrible pain in patients' legs), RASH (rash on face/rash halfway down patients' chest), LETHARGY (lethargic), DIZZINESS (Patient feels dizzy) and FEELING ABNORMAL (patient feels like he is not all there) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (horrible pain in patients' legs), RASH (rash on face/rash halfway down patients' chest), LETHARGY (lethargic), DIZZINESS (Patient feels dizzy) and FEELING ABNORMAL (patient feels like he is not all there). At the time of the report, PAIN IN EXTREMITY (horrible pain in patients' legs), RASH (rash on face/rash halfway down patients' chest), LETHARGY (lethargic), DIZZINESS (Patient feels dizzy) and FEELING ABNORMAL (patient feels like he is not all there) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication reported.  Treatment information not provided.     Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Illness, Lymphadenopathy, Pyrexia
Clinical narrative: 8 days later the patient developed shingles on the same side of her body that she received the vaccine in; Fever; Swollen glands; felt sick; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ILLNESS (felt sick), HERPES ZOSTER (8 days later the patient developed shingles on the same side of her body that she received the vaccine in), PYREXIA (Fever) and LYMPHADENOPATHY (Swollen glands) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METHYLPREDNISOLONE ACETATE (MEDROL [METHYLPREDNISOLONE ACETATE]) and GANCICLOVIR for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced ILLNESS (felt sick), PYREXIA (Fever) and LYMPHADENOPATHY (Swollen glands). On an unknown date, the patient experienced HERPES ZOSTER (8 days later the patient developed shingles on the same side of her body that she received the vaccine in). At the time of the report, ILLNESS (felt sick), HERPES ZOSTER (8 days later the patient developed shingles on the same side of her body that she received the vaccine in), PYREXIA (Fever) and LYMPHADENOPATHY (Swollen glands) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Headache, Myalgia, Nausea
Clinical narrative: Concomitant products included VITAMIN D NOS, CALCIUM and VALSARTAN for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced DIARRHOEA (diarrhea), ASTHENIA (weakness), TREMOR (shaking), HEADACHE (headache), MYALGIA (muscle aches) and NAUSEA (nausea). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), ASTHENIA (weakness), TREMOR (shaking), HEADACHE (headache), MYALGIA (muscle aches) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-022057 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Concomitant products included VITAMIN D NOS, CALCIUM and VALSARTAN for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced DIARRHOEA (diarrhea), ASTHENIA (weakness), TREMOR (shaking), HEADACHE (headache), MYALGIA (muscle aches) and NAUSEA (nausea). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), ASTHENIA (weakness), TREMOR (shaking), HEADACHE (headache), MYALGIA (muscle aches) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-022057 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Injection site is a little red, lower down on the arm, there is a circle on her right arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection site is a little red, lower down on the arm, there is a circle on her right arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site is a little red, lower down on the arm, there is a circle on her right arm). At the time of the report, VACCINATION SITE ERYTHEMA (Injection site is a little red, lower down on the arm, there is a circle on her right arm) outcome was unknown. Not Provided          Concomitant medications were not provided. Treatment information was not reported.    This case was linked to MOD-2021-029193 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: potential Adverse Event; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (potential Adverse Event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (potential Adverse Event). At the time of the report, ADVERSE EVENT (potential Adverse Event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Dyspepsia, Fatigue, Sluggishness
Clinical narrative: sluggish like tired; no appetite; very tired; arm of injection really hurt; hard burn; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (hard burn), DIZZINESS (dizziness), SLUGGISHNESS (sluggish like tired), DECREASED APPETITE (no appetite) and FATIGUE (very tired) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 21521 and 12121) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D [VITAMIN D NOS] and VITAMIN B12 NOS for an unknown indication.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DYSPEPSIA (hard burn), DIZZINESS (dizziness), FATIGUE (very tired) and VACCINATION SITE PAIN (arm of injection really hurt). On 17-Feb-2021, the patient experienced SLUGGISHNESS (sluggish like tired) and DECREASED APPETITE (no appetite). The patient was treated with PARACETAMOL (TYLENOL) for Heartburn, at an unspecified dose and frequency. At the time of the report, DYSPEPSIA (hard burn), DIZZINESS (dizziness), FATIGUE (very tired) and VACCINATION SITE PAIN (arm of injection really hurt) outcome was unknown and SLUGGISHNESS (sluggish like tired) and DECREASED APPETITE (no appetite) had not resolved.            Other concomitant medications included self pain and blood pressure medications.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sluggish like tired; no appetite; very tired; arm of injection really hurt; hard burn; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (hard burn), DIZZINESS (dizziness), SLUGGISHNESS (sluggish like tired), DECREASED APPETITE (no appetite) and FATIGUE (very tired) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 21521 and 12121) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D [VITAMIN D NOS] and VITAMIN B12 NOS for an unknown indication.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DYSPEPSIA (hard burn), DIZZINESS (dizziness), FATIGUE (very tired) and VACCINATION SITE PAIN (arm of injection really hurt). On 17-Feb-2021, the patient experienced SLUGGISHNESS (sluggish like tired) and DECREASED APPETITE (no appetite). The patient was treated with PARACETAMOL (TYLENOL) for Heartburn, at an unspecified dose and frequency. At the time of the report, DYSPEPSIA (hard burn), DIZZINESS (dizziness), FATIGUE (very tired) and VACCINATION SITE PAIN (arm of injection really hurt) outcome was unknown and SLUGGISHNESS (sluggish like tired) and DECREASED APPETITE (no appetite) had not resolved.            Other concomitant medications included self pain and blood pressure medications.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypersensitivity, Nausea, Rash macular
Clinical narrative: dizzy; red spot underneath the shot mark; nausea; allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction), DIZZINESS (dizzy), RASH MACULAR (red spot underneath the shot mark) and NAUSEA (nausea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL and VITAMINS NOS for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced DIZZINESS (dizzy), RASH MACULAR (red spot underneath the shot mark) and NAUSEA (nausea). In February 2021, the patient experienced HYPERSENSITIVITY (allergic reaction). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (allergic reaction), DIZZINESS (dizzy), RASH MACULAR (red spot underneath the shot mark) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Rash, Skin reaction
Clinical narrative: covid arm; a rash; it itches; a little swollen; This spontaneous case was reported by a patient and describes the occurrence of SKIN REACTION (covid arm), RASH (a rash), PRURITUS (it itches) and PERIPHERAL SWELLING (a little swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced SKIN REACTION (covid arm), RASH (a rash) and PRURITUS (it itches). 11-Feb-2021, the patient experienced PERIPHERAL SWELLING (a little swollen). At the time of the report, SKIN REACTION (covid arm), RASH (a rash), PRURITUS (it itches) and PERIPHERAL SWELLING (a little swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Gait disturbance, Lip pain, Pain in extremity
Clinical narrative: Couldn't walk for a second and it went away, very brief; Sore arm; Cold sore, Canker sore on inside of lip; Low grade fever; Weird feeling; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Couldn't walk for a second and it went away, very brief), PAIN IN EXTREMITY (Sore arm), LIP PAIN (Cold sore, Canker sore on inside of lip), FEELING ABNORMAL (Weird feeling) and PYREXIA (Low grade fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Herpes NOS (She sometimes gets herpes break outs).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FEELING ABNORMAL (Weird feeling). On an unknown date, the patient experienced GAIT DISTURBANCE (Couldn't walk for a second and it went away, very brief), PAIN IN EXTREMITY (Sore arm), LIP PAIN (Cold sore, Canker sore on inside of lip) and PYREXIA (Low grade fever). At the time of the report, GAIT DISTURBANCE (Couldn't walk for a second and it went away, very brief), PAIN IN EXTREMITY (Sore arm), LIP PAIN (Cold sore, Canker sore on inside of lip) and PYREXIA (Low grade fever) outcome was unknown and FEELING ABNORMAL (Weird feeling) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) low grade fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was also having MACFS as concomitant medication for chronic fatigue syndrome. Treatment information was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Couldn't walk for a second and it went away, very brief; Sore arm; Cold sore, Canker sore on inside of lip; Low grade fever; Weird feeling; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Couldn't walk for a second and it went away, very brief), PAIN IN EXTREMITY (Sore arm), LIP PAIN (Cold sore, Canker sore on inside of lip), FEELING ABNORMAL (Weird feeling) and PYREXIA (Low grade fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Herpes NOS (She sometimes gets herpes break outs).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FEELING ABNORMAL (Weird feeling). On an unknown date, the patient experienced GAIT DISTURBANCE (Couldn't walk for a second and it went away, very brief), PAIN IN EXTREMITY (Sore arm), LIP PAIN (Cold sore, Canker sore on inside of lip) and PYREXIA (Low grade fever). At the time of the report, GAIT DISTURBANCE (Couldn't walk for a second and it went away, very brief), PAIN IN EXTREMITY (Sore arm), LIP PAIN (Cold sore, Canker sore on inside of lip) and PYREXIA (Low grade fever) outcome was unknown and FEELING ABNORMAL (Weird feeling) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) low grade fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was also having MACFS as concomitant medication for chronic fatigue syndrome. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus, Oropharyngeal discomfort
Clinical narrative: scratchiness in throat; Itchiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (scratchiness in throat) and INJECTION SITE PRURITUS (Itchiness at injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (scratchiness in throat) and INJECTION SITE PRURITUS (Itchiness at injection site). On 29-Jan-2021, OROPHARYNGEAL DISCOMFORT (scratchiness in throat) and INJECTION SITE PRURITUS (Itchiness at injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products information was not reported. Treatment information was not provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pollakiuria
Clinical narrative: Chills; Urinating (More often); This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and POLLAKIURIA (Urinating (More often)) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced CHILLS (Chills) and POLLAKIURIA (Urinating (More often)). At the time of the report, CHILLS (Chills) and POLLAKIURIA (Urinating (More often)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Chest X-ray, Chest pain, Chills
Clinical narrative: Weakness after eating; trouble breathing is on/off; Chest pain; Trouble Breathing; Weakness; Body aches; Chills; Fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYALGIA (Body aches), CHILLS (Chills), PYREXIA (Fever), CHEST PAIN (Chest pain) and DYSPNOEA (Trouble Breathing) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE for Blood pressure, ROSUVASTATIN for High cholesterol.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever). On 13-Feb-2021, the patient experienced CHEST PAIN (Chest pain), DYSPNOEA (Trouble Breathing) and ASTHENIA (Weakness). On 16-Feb-2021, the patient experienced ASTHENIA (Weakness after eating) and DYSPNOEA (trouble breathing is on/off). On 09-Feb-2021, MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever) had resolved. On 15-Feb-2021, CHEST PAIN (Chest pain) had resolved, ASTHENIA (Weakness) outcome was unknown. At the time of the report, DYSPNOEA (Trouble Breathing), ASTHENIA (Weakness after eating) and DYSPNOEA (trouble breathing is on/off) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Blood test: normal. In February 2021, Chest X-ray: normal. In February 2021, Electrocardiogram: normal. In February 2021, SARS-CoV-2 test negative: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram, Myalgia, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Weakness after eating; trouble breathing is on/off; Chest pain; Trouble Breathing; Weakness; Body aches; Chills; Fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYALGIA (Body aches), CHILLS (Chills), PYREXIA (Fever), CHEST PAIN (Chest pain) and DYSPNOEA (Trouble Breathing) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE for Blood pressure, ROSUVASTATIN for High cholesterol.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever). On 13-Feb-2021, the patient experienced CHEST PAIN (Chest pain), DYSPNOEA (Trouble Breathing) and ASTHENIA (Weakness). On 16-Feb-2021, the patient experienced ASTHENIA (Weakness after eating) and DYSPNOEA (trouble breathing is on/off). On 09-Feb-2021, MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever) had resolved. On 15-Feb-2021, CHEST PAIN (Chest pain) had resolved, ASTHENIA (Weakness) outcome was unknown. At the time of the report, DYSPNOEA (Trouble Breathing), ASTHENIA (Weakness after eating) and DYSPNOEA (trouble breathing is on/off) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Blood test: normal. In February 2021, Chest X-ray: normal. In February 2021, Electrocardiogram: normal. In February 2021, SARS-CoV-2 test negative: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Malaise
Clinical narrative: malaise; loss of appetite; was down for a day; chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (malaise), DECREASED APPETITE (loss of appetite), ASTHENIA (was down for a day) and CHILLS (chills) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced MALAISE (malaise), DECREASED APPETITE (loss of appetite), ASTHENIA (was down for a day) and CHILLS (chills). On 15-Feb-2021, MALAISE (malaise), DECREASED APPETITE (loss of appetite), ASTHENIA (was down for a day) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: chills; fever; headache; muscle/body aches; fatigue; nausea; loose stool; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/body aches) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/body aches), FATIGUE (fatigue), NAUSEA (nausea), DIARRHOEA (loose stool) and ARTHRALGIA (joint pain). At the time of the report, CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/body aches), FATIGUE (fatigue), NAUSEA (nausea), DIARRHOEA (loose stool) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: chills; fever; headache; muscle/body aches; fatigue; nausea; loose stool; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/body aches) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/body aches), FATIGUE (fatigue), NAUSEA (nausea), DIARRHOEA (loose stool) and ARTHRALGIA (joint pain). At the time of the report, CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/body aches), FATIGUE (fatigue), NAUSEA (nausea), DIARRHOEA (loose stool) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Oral mucosal eruption, Throat irritation
Clinical narrative: rash inside her mouth; scratchy throat; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL ERUPTION (rash inside her mouth) and THROAT IRRITATION (scratchy throat) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced ORAL MUCOSAL ERUPTION (rash inside her mouth) and THROAT IRRITATION (scratchy throat). At the time of the report, ORAL MUCOSAL ERUPTION (rash inside her mouth) and THROAT IRRITATION (scratchy throat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details was not provided. No relevant concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: Fever; Fatigue; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), FATIGUE (Fatigue) and PAIN (body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), FATIGUE (Fatigue) and PAIN (body aches). At the time of the report, PYREXIA (Fever), FATIGUE (Fatigue) and PAIN (body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Injection site erythema, Pruritus, Vaccination site rash, Vaccination site reaction
Clinical narrative: rash around the vaccination site; itchy; inflamed; 2 to 3 inch red spot on the arm around the injection site; Persistent spot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Feb-2021 and was forwarded to Moderna on 17-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash around the vaccination site), PRURITUS (itchy), INFLAMMATION (inflamed), INJECTION SITE ERYTHEMA (2 to 3 inch red spot on the arm around the injection site) and VACCINATION SITE REACTION (Persistent spot) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE BESILATE, VALSARTAN (EXFORGE), NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), BUMETANIDE (BUMEX), MULTIVITAMIN & MINERAL, ASCORBIC ACID, BETA VULGARIS ROOT, IRON AMINO ACID CHELATE, ROSA CANINA FRUIT, RUBUS IDAEUS LEAF (IRON SUPPLEMENT WITH VIT C & HERBS) and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash around the vaccination site), PRURITUS (itchy), INFLAMMATION (inflamed), INJECTION SITE ERYTHEMA (2 to 3 inch red spot on the arm around the injection site) and VACCINATION SITE REACTION (Persistent spot). At the time of the report, VACCINATION SITE RASH (rash around the vaccination site), PRURITUS (itchy), INFLAMMATION (inflamed), INJECTION SITE ERYTHEMA (2 to 3 inch red spot on the arm around the injection site) and VACCINATION SITE REACTION (Persistent spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included BENADRYL AND CORTISONE CREAM.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Chest pain, Diarrhoea, Rash papular, Secretion discharge
Clinical narrative: Diarrhea; Abdominal Pain; Chest Pain; Green Mucus Coming Out of Nose; Bumps - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ABDOMINAL PAIN (Abdominal Pain), CHEST PAIN (Chest Pain), SECRETION DISCHARGE (Green Mucus Coming Out of Nose) and RASH PAPULAR (Bumps - Near Injection Site) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), ABDOMINAL PAIN (Abdominal Pain), CHEST PAIN (Chest Pain), SECRETION DISCHARGE (Green Mucus Coming Out of Nose) and RASH PAPULAR (Bumps - Near Injection Site). The patient was treated with HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), ABDOMINAL PAIN (Abdominal Pain), CHEST PAIN (Chest Pain), SECRETION DISCHARGE (Green Mucus Coming Out of Nose) and RASH PAPULAR (Bumps - Near Injection Site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Hypoaesthesia, Injection site erythema, Nausea
Clinical narrative: Nausea; Numbness under left chin; Numbness in left cheek; Numbness to whole left side; Pain at injection site; Red at injection site; Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness under left chin), HYPOAESTHESIA (Numbness in left cheek), HYPOAESTHESIA (Numbness to whole left side), VACCINATION SITE PAIN (Pain at injection site) and INJECTION SITE ERYTHEMA (Red at injection site) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness under left chin), HYPOAESTHESIA (Numbness in left cheek), HYPOAESTHESIA (Numbness to whole left side), VACCINATION SITE PAIN (Pain at injection site), INJECTION SITE ERYTHEMA (Red at injection site), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). On 16-Feb-2021, the patient experienced NAUSEA (Nausea). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (Numbness under left chin), HYPOAESTHESIA (Numbness in left cheek), HYPOAESTHESIA (Numbness to whole left side), VACCINATION SITE PAIN (Pain at injection site), INJECTION SITE ERYTHEMA (Red at injection site), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Nausea; Numbness under left chin; Numbness in left cheek; Numbness to whole left side; Pain at injection site; Red at injection site; Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness under left chin), HYPOAESTHESIA (Numbness in left cheek), HYPOAESTHESIA (Numbness to whole left side), VACCINATION SITE PAIN (Pain at injection site) and INJECTION SITE ERYTHEMA (Red at injection site) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness under left chin), HYPOAESTHESIA (Numbness in left cheek), HYPOAESTHESIA (Numbness to whole left side), VACCINATION SITE PAIN (Pain at injection site), INJECTION SITE ERYTHEMA (Red at injection site), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). On 16-Feb-2021, the patient experienced NAUSEA (Nausea). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (Numbness under left chin), HYPOAESTHESIA (Numbness in left cheek), HYPOAESTHESIA (Numbness to whole left side), VACCINATION SITE PAIN (Pain at injection site), INJECTION SITE ERYTHEMA (Red at injection site), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Body is itching all around; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Body is itching all around) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Body is itching all around). At the time of the report, PRURITUS (Body is itching all around) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.  Treatment medication was not provided.  The patient wants to know was this a side effect or an allergic reaction. And whether want to take another dose or not.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Oral pain
Clinical narrative: Soreness in mouth and teeth; mouth is very sensitive; This spontaneous case was reported by a consumer and describes the occurrence of ORAL PAIN (Soreness in mouth and teeth) and ORAL PAIN (mouth is very sensitive) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ORAL PAIN (Soreness in mouth and teeth) and ORAL PAIN (mouth is very sensitive). At the time of the report, ORAL PAIN (Soreness in mouth and teeth) and ORAL PAIN (mouth is very sensitive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever of 100.6 F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100.6 F) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).   On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 100.6 F). At the time of the report, PYREXIA (Fever of 100.6 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: abnormal (High) 100.6 degrees Fahrenheit.         Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity
Clinical narrative: dizziness; sore arm for some time; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm for some time) and DIZZINESS (dizziness) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm for some time). In February 2021, the patient experienced DIZZINESS (dizziness). At the time of the report, PAIN IN EXTREMITY (sore arm for some time) had resolved and DIZZINESS (dizziness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pruritus
Clinical narrative: Arm soreness; Itching injection site; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) and VACCINATION SITE PRURITUS (Itching injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm soreness) and VACCINATION SITE PRURITUS (Itching injection site). At the time of the report, PAIN IN EXTREMITY (Arm soreness) and VACCINATION SITE PRURITUS (Itching injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment reported. No concomitant medication reported.